Forte Biosciences, Inc. (FBRX)

NASDAQ: FBRX · IEX Real-Time Price · USD

0.590

+0.029 (5.17%)

At close: Jul 19, 2024, 4:00 PM

0.600

+0.010 (1.69%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Forte Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Selling, General & Admin	12.01	10.62	8.3	7.63	4.22	1.38	Upgrade
Research & Development	21.43	21.86	5.59	13.85	10	2.68	Upgrade
Other Operating Expenses	0	0	0	0	32.06	0	Upgrade
Operating Expenses	33.44	32.49	13.9	21.49	46.28	4.06	Upgrade
Operating Income	-33.44	-32.49	-13.9	-21.49	-46.28	-4.06	Upgrade
Other Expense / Income	-1.29	-1.01	-0.02	0.22	0.21	0.01	Upgrade
Pretax Income	-32.14	-31.48	-13.88	-21.71	-46.49	-4.07	Upgrade
Net Income	-32.14	-31.48	-13.88	-21.71	-46.49	-4.07	Upgrade
Shares Outstanding (Basic)	46	32	17	14	7	2	Upgrade
Shares Outstanding (Diluted)	46	32	17	14	7	2	Upgrade
Shares Change	119.37%	81.61%	24.45%	89.81%	249.05%	57.65%	Upgrade
EPS (Basic)	-0.88	-1.00	-0.80	-1.55	-6.32	-1.93	Upgrade
EPS (Diluted)	-0.88	-1.00	-0.80	-1.55	-6.32	-1.93	Upgrade
Free Cash Flow	-30.26	-28.79	-8.19	-16.68	-18.42	-2.93	Upgrade
Free Cash Flow Per Share	-0.66	-0.91	-0.47	-1.19	-2.50	-1.39	Upgrade
EBITDA	-32.13	-31.47	-13.88	-21.67	-46.43	-4.06	Upgrade
Depreciation & Amortization	0.02	0.01	0	0.04	0.05	0.01	Upgrade
EBIT	-32.14	-31.48	-13.88	-21.71	-46.49	-4.07	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).